[Federal Register Volume 77, Number 176 (Tuesday, September 11, 2012)]
[Notices]
[Pages 55845-55846]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-22210]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2012-N-0001]
Science Board to the Food and Drug Administration: Request for
Nominations
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is requesting
nominations to serve on the Science Board to FDA (Science Board).
FDA seeks to include the views of women and men, members of all
racial and ethnic groups, and individuals with and without disabilities
on its advisory committees and, therefore, encourages nominations of
appropriately qualified candidates from these groups.
DATES: Nominations received on or before October 11, 2012 will be given
first consideration for membership on the Science Board. Nominations
received after October 11, 2012 will be considered for nomination to
the Board should nominees still be needed.
ADDRESSES: All nominations for membership should be sent electronically
to [email protected] or by mail to Advisory Committee Oversight and
Management Staff, 10903 New Hampshire Ave., Bldg. 32, rm. 5103, Silver
Spring, MD 20993-0002.
FOR FURTHER INFORMATION CONTACT: Regarding all nomination questions for
membership, the primary contact is Martha Monser, Office of the Chief
Scientist, Food and Drug Administration, 10903 New Hampshire Ave.,
Bldg. 32, rm. 4286, Silver Spring, MD 20993-0002, 301-796-4627, email:
[email protected].
[[Page 55846]]
Information about becoming a member on an FDA advisory committee
can also be obtained by visiting FDA's Web site by using the following
link http://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/CommitteeMembership/default.htm.
SUPPLEMENTARY INFORMATION: FDA is requesting nominations to the Science
Board. The Science Board will meet approximately three times a year.
Meetings of the Science Board will be open to the public. All meetings
will be announced in the Federal Register at least 15 days prior to
each public meeting.
I. General Function of the Committee
The Science Board shall provide advice primarily to the
Commissioner and other appropriate officials on specific complex
scientific and technical issues important to FDA and its mission,
including emerging issues within the scientific community.
Additionally, the Science Board will provide advice that supports the
Agency in keeping pace with technical and scientific developments,
including in regulatory science and input into the Agency's research
agenda and on upgrading its scientific and research facilities and
training opportunities. It will also provide, where requested, expert
review of Agency sponsored intramural and extramural scientific
research programs.
II. Desired Expertise
FDA is specifically considering persons knowledgeable in the fields
of food science, safety, and nutrition; chemistry; pharmacology;
translational and clinical medicine and research; toxicology;
biostatistics; medical devices; imaging; robotics; cell and tissue
based products; regenerative medicine; public health and epidemiology;
international health and regulation; product safety; product
manufacturing sciences and quality; and other scientific areas relevant
to FDA-regulated products such as systems biology, informatics,
nanotechnology, and combination products. Members shall be chosen from
academia and industry. The Science Board may also include technically
qualified federal members.
III. Nomination Procedures
Any interested person may nominate one or more qualified person(s)
for membership on the Science Board. Self nominations are also
accepted. Nominations shall include the name of the committee, complete
curriculum vitae of each nominee, and their current business address
and/or home address, telephone number, and email address, if available.
Nominations must also acknowledge that the nominee is aware of the
nomination unless self-nominated. FDA will ask the potential candidates
to provide detailed information concerning such matters related to
financial holdings, employment, and research grants and/or contracts to
permit evaluation of possible sources of conflict of interest.
This notice is issued under the Federal Advisory Act (5 U.S.C. app.
2) and 21 CFR part 14 relating to advisory committees.
Dated: Sept. 5, 2012.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2012-22210 Filed 9-10-12; 8:45 am]
BILLING CODE 4160-01-P